Kira Pharmacenticals (US), LLC.
4 clinical trials · Sponsor
◉ Watch Kira Pharmacenticals (US), LLC.
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis (NCT05517980) | Kira Pharmacenticals (US), LLC. | 2025-03-01 |
| Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus (NCT05504187) | Kira Pharmacenticals (US), LLC. | 2025-03-01 |
| To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104 (NCT05476887) | Kira Pharmacenticals (US), LLC. | 2022-11-25 |
| To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104 (NCT05490017) | Kira Pharmacenticals (US), LLC. | 2020-12-30 |
Track Kira Pharmacenticals (US), LLC. automatically
Every clearance here is in the API, with alerts when new ones post.